FDA Clearance Tracker · P970043-S006
LADAR VISION EXCIMER LASER SYSTEM
Last checked: Nov 20, 2026Latest source record: Jan 7, 2000 (this decision)Source: openFDAMethods & limitations
Decided
Jan 7, 2000
Approved
Time to decision
107 days
Received Sep 22, 1999. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P970043-S006
- Device name
- LADAR VISION EXCIMER LASER SYSTEM
- Applicant
- Alcon Laboratories
- Applicant location
- Fort Worth, TX
- Received
- Sep 22, 1999
- Decided
- Jan 7, 2000
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P970043
Device type
- Device type
- Excimer laser system (LZS)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Addition of the following statement to the warnings section: "A minimum of pre-operative pupillary dilation of 7mm and a maximum dilation of 11mm must be achieved and maintained in all patients throughout the refractive procedure to optimize tracker performance.
Source documents
Other decisions for Alcon Laboratories
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K254052 · Decided Feb 13, 2026 · 58 days after receipt
Device type: Lenses, Soft Contact, Daily Wear (LPL) · Ophthalmology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.